SCHEMBL22988909

SCHEMBL22988909

c1ccc(-c2nc(-c3ccc(-n4c5ccc6cccc7oc8cccc9ccc4c(c98)c5c67)c4ccccc34)nc(-c3cccc4c3oc3ccccc34)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.35
MAPT P10636 7/20 0.34
ALDH1A1 P00352 5/20 0.34
TSHR P16473 4/20 0.34
KDM4E B2RXH2 4/20 0.34
LMNA P02545 4/20 0.34
HSD17B10 Q99714 3/20 0.34
POLB P06746 2/20 0.34
MAPK1 P28482 2/20 0.34
PRKDC P78527 2/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
KMT2A Q03164 2/20 0.33
HTT P42858 1/20 0.33
HPGD P15428 2/20 0.32
TP53 P04637 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22989245 0.92 ALOX5 (0.32) ALOX5MAPTALDH1A1TSHRKDM4E
SCHEMBL22988960 0.90 MAPT (0.36) MAPTALDH1A1TSHRKDM4ELMNA
SCHEMBL24151612 0.87 ALOX5 (0.39) ALOX5MAPTALDH1A1TSHRKDM4E
SCHEMBL22988914 0.85 PRKDC (0.33) ALOX5MAPTALDH1A1KDM4EPRKDC
SCHEMBL22257555 0.85 KDM4E (0.32) MAPTALDH1A1TSHRKDM4EHSD17B10
SCHEMBL22988606 0.85 KDM4E (0.33) MAPTALDH1A1TSHRKDM4EHSD17B10
SCHEMBL24154016 0.85 TSHR (0.36) MAPTALDH1A1TSHRKDM4EHSD17B10
SCHEMBL22989019 0.84 ALOX5 (0.34) ALOX5MAPTALDH1A1TSHRKDM4E
SCHEMBL22850188 0.84 ALOX5 (0.33) ALOX5MAPTALDH1A1TSHRKDM4E
SCHEMBL24152219 0.84 ALOX5 (0.39) ALOX5MAPTALDH1A1TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021029757-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2021-02-18 WO disclosed
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 AUSPEX PHARMACEUTICALS, INC. 2016-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 JAK2, JAK3, PAK3 ALOX5 1566/4885MAPT 2964/4885ALDH1A1 1603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.